ADVM - Adverum Biotechnologies, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5415.12M
Enterprise Value 3263.22M
Trailing P/E N/A
Forward P/E 1-5.75
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)459.71
Price/Book (mrq)2.33
Enterprise Value/Revenue 3291.50
Enterprise Value/EBITDA 6-4.41

Trading Information

Stock Price History

Beta (3Y Monthly) 2.33
52-Week Change 33.00%
S&P500 52-Week Change 32.99%
52 Week High 316.38
52 Week Low 32.62
50-Day Moving Average 310.47
200-Day Moving Average 39.35

Share Statistics

Avg Vol (3 month) 31.99M
Avg Vol (10 day) 37.94M
Shares Outstanding 564.46M
Float 35.47M
% Held by Insiders 111.22%
% Held by Institutions 173.40%
Shares Short (Aug 15, 2019) 49.31M
Short Ratio (Aug 15, 2019) 47.88
Short % of Float (Aug 15, 2019) 416.74%
Short % of Shares Outstanding (Aug 15, 2019) 414.44%
Shares Short (prior month Jul 15, 2019) 47.58M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-6,781.95%

Management Effectiveness

Return on Assets (ttm)-16.77%
Return on Equity (ttm)-32.13%

Income Statement

Revenue (ttm)903k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-48.52M
EBITDA -59.74M
Net Income Avi to Common (ttm)-66.06M
Diluted EPS (ttm)-1.05
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)177.64M
Total Cash Per Share (mrq)2.76
Total Debt (mrq)25.75M
Total Debt/Equity (mrq)14.48
Current Ratio (mrq)17.79
Book Value Per Share (mrq)2.76

Cash Flow Statement

Operating Cash Flow (ttm)-54.44M
Levered Free Cash Flow (ttm)-37.29M